Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Single-blind, Active-Controlled, Parallel Group, Phase III Clinical Study Report to Evaluate the Efficacy and Safety of 'Hemofence' for Hemostasis in Patients With Exudative Hemorrhage Uncontrolled or Ineffectively Controlled by Conventional Procedures in Spinal/Orthopedic Surgery

NCT07824024 is registered in ClinicalTrials.gov with BMI Korea as lead sponsor.

NCT NCT07824024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07824024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Single-blind, Active-Controlled, Parallel Group, Phase III Clinical Study Report to Evaluate the Efficacy and Safety of 'Hemofence' for Hemostasis in Patients With Exudative Hemorrhage Uncontrolled or Ineffectively Controlled by Conventional Procedures in Spinal/Orthopedic Surgery
Lead sponsor
BMI Korea
Phase
Phase 3
Overall status
Completed
Start date
December 3, 2020
Completion date
April 19, 2022
Enrollment
172 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

surgical hemorrhage